Loading
AINOS
Ainos, Inc. is a dual-platform AI and biotech company. The Company offers a platform that turns invisible chemical signals into machine-readable data, as well as develops low-dose oral interferon therapeutic for treatment of autoimmune and infectious diseases. Ainos serves clients worldwide.
Funding
Every round, secondary, debt facility or acquisition involving AINOS that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
—